Track the 영진약품 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 영진약품 has published 6 public disclosures. Market capitalisation: €215.6bn. The latest transaction was reported on 5 March 2026 (Other). Among the most active insiders: 영진약품. Every trade is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
영진약품 is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the research, development, and manufacturing of pharmaceutical products.